The Biden administration to waive patents on corona vaccines. India to gain

 “No one is safe until everyone is safe”.

Only drug companies that own patents are authorized to manufacture Covid vaccines. A lifting of the patent will allow the formulas to be shared and there will no longer be an embargo —

This will lead to cheaper and more generic versions of Covid vaccines. It will also mean two things — vaccines will be more affordable and this will be a big step in overcoming vaccine shortage.

“I understand under normal circumstances the importance of protecting investments and [research and development] and intellectual property and in truth, it won’t be that easy for the world to ramp up vaccines because they’ll have to build up infrastructure,” said Bera, one of four Indian Americans in Congress who called on Biden to send aid to India.

 President Biden, faced with the surging Covid-19 crises in India and South America, is under intensifying pressure from the international community and his party’s left flank to commit to increasing the vaccine supply by loosening patent and intellectual property protections on Covid vaccines.